ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells
- PMID: 21165575
- DOI: 10.3892/or.2010.1102
ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells
Abstract
Most tumors in the central nervous system are drug resistant partly because of the presence of the blood-brain barrier (BBB) between circulating blood and tumor tissues. Primary central nervous system lymphoma (PCNSL) is one of the exceptions, as it is highly sensitive to high-dose methotrexate (MTX)-based chemotherapy. The aim of this study was to evaluate the BBB function of tumor capillary endothelial cells in PCNSL. Expression of three major drug efflux transporters that belong to the ATP-binding cassette (ABC) superfamily, P-glycoprotein encoded by the human multidrug resistance gene (MDR1 Pgp; ABCB1), breast cancer resistance protein (BCRP; ABCG2), and multidrug resistance-associated protein 1 (MRP1; ABCC1), was evaluated. Immunohistochemistry was performed in capillary endothelial cells of 30 tumor areas from 22 PCNSL cases and compared with that of 30 gliomas. The microenvironment around tumor capillaries was assessed by examining the distribution of astrocytes and by counting the number of macrophages and T-cells, the principal cytokine producers. In PCNSL, expression of MDR1 Pgp and BCRP in tumor capillary endothelial cells was decreased in 63 and 93% of tumor areas examined, respectively, and these reduction levels differed significantly from those of gliomas (P<0.05). When the PCNSLs were further segregated by way of infiltration of tumor cells into three patterns (dense, perivascular and sparse), decreased MDR1 Pgp and BCRP in tumor capillary endothelial cells were much more prominent in dense and perivascular patterns. In all tumors and non-tumor areas of the brain, MRP1 was undetected on capillary endothelial cells. Assessment of the microenvironment around the tumor capillaries suggested that dissociation from astrocytes and infiltration of macrophages and T-cells was involved in the down-regulation of MDR1 Pgp and BCRP in capillary endothelial cells. In conclusion, we report that expression of the major ABC transporters of the BBB, MDR1 Pgp and BCRP, decreases in tumor capillary endothelial cells of PCNSL. Thus, decreased expression may permit delivery of chemotherapeutic agents to the tumor tissues.
Similar articles
-
Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.Exp Oncol. 2013 Dec;35(4):287-90. Exp Oncol. 2013. PMID: 24382439
-
P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.Pharmacol Res. 2013 Oct;76:9-16. doi: 10.1016/j.phrs.2013.06.009. Epub 2013 Jul 1. Pharmacol Res. 2013. PMID: 23827160
-
Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer.Oncol Rep. 2012 Jan;27(1):265-9. doi: 10.3892/or.2011.1475. Epub 2011 Sep 28. Oncol Rep. 2012. PMID: 21956451
-
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.Toxicol Appl Pharmacol. 2005 May 1;204(3):216-37. doi: 10.1016/j.taap.2004.10.012. Toxicol Appl Pharmacol. 2005. PMID: 15845415 Review.
-
Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.Int J Toxicol. 2006 Jul-Aug;25(4):231-59. doi: 10.1080/10915810600746023. Int J Toxicol. 2006. PMID: 16815813 Review.
Cited by
-
A Comprehensive Review of Cross-Linked Gels as Vehicles for Drug Delivery to Treat Central Nervous System Disorders.Gels. 2022 Sep 6;8(9):563. doi: 10.3390/gels8090563. Gels. 2022. PMID: 36135275 Free PMC article. Review.
-
(67/68)Galmydar: A metalloprobe for monitoring breast cancer resistance protein (BCRP)-mediated functional transport activity.Nucl Med Biol. 2016 Mar;43(3):191-7. doi: 10.1016/j.nucmedbio.2015.12.001. Epub 2015 Dec 8. Nucl Med Biol. 2016. PMID: 26924499 Free PMC article.
-
Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells.Exp Ther Med. 2014 Nov;8(5):1611-1615. doi: 10.3892/etm.2014.1932. Epub 2014 Aug 26. Exp Ther Med. 2014. PMID: 25289068 Free PMC article.
-
Ubc9 expression predicts chemoresistance in breast cancer.Chin J Cancer. 2011 Sep;30(9):638-44. doi: 10.5732/cjc.011.10084. Chin J Cancer. 2011. PMID: 21880185 Free PMC article.
-
Unconjugated bilirubin elevation impairs the function and expression of breast cancer resistance protein (BCRP) at the blood-brain barrier in bile duct-ligated rats.Acta Pharmacol Sin. 2016 Aug;37(8):1129-40. doi: 10.1038/aps.2016.25. Epub 2016 May 16. Acta Pharmacol Sin. 2016. PMID: 27180978 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous